Prognostic factors and outcomes for pediatric patients receiving an haploidentical relative allogeneic transplant using CD3/CD19-depleted grafts
暂无分享,去创建一个
M. Díaz | A. Pérez‐Martínez | B. Herrero | M. González-Vicent | J. Ruiz | N. Deltoro | J. Vicario | I. Martínez | L. Abad | E. Merino | M. Ramírez | J. Sevilla
[1] T. Spitzer,et al. Engraftment syndrome: double-edged sword of hematopoietic cell transplants , 2015, Bone Marrow Transplantation.
[2] F. Locatelli,et al. KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. , 2014, Blood.
[3] B. Gruhn,et al. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia , 2014, British journal of haematology.
[4] L. Kanz,et al. KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts , 2014, Annals of Hematology.
[5] P. Veys,et al. The current role of T cell depletion in paediatric stem cell transplantation , 2013, British journal of haematology.
[6] J. W. Lee,et al. Peri-engraftment syndrome in allogeneic hematopoietic SCT , 2013, Bone Marrow Transplantation.
[7] J. Stockman. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia , 2013 .
[8] R. Corvò,et al. In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study , 2013, Bone Marrow Transplantation.
[9] R. Handgretinger. New approaches to graft engineering for haploidentical bone marrow transplantation. , 2012, Seminars in oncology.
[10] R. Handgretinger. Negative depletion of CD3+ and TcR&agr;&bgr;+ T cells , 2012, Current opinion in hematology.
[11] Á. Lassaletta,et al. Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia , 2012, Bone Marrow Transplantation.
[12] K. Alimoghaddam,et al. The Outcome of Allogeneic Hematopoietic Stem Cell Transplants Without Total Body Irradiation in Pediatric Patients With Acute Lymphoblastic Leukemia: Single Centre Experience , 2012, Journal of pediatric hematology/oncology.
[13] M. Díaz,et al. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single‐center retrospective study , 2011, European journal of haematology.
[14] M. Díaz,et al. Graft Manipulation and Reduced-intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation From Mismatched Unrelated and Mismatched/Haploidentical Related Donors in Pediatric Leukemia Patients , 2010, Journal of pediatric hematology/oncology.
[15] F. Gumy-Pause,et al. Report of a Successful Treatment of Pulmonary Cunninghamella bertholletiae Infection With Liposomal Amphotericin and Posaconazole in a Child With GvHD and Review of the Literature , 2010, Journal of pediatric hematology/oncology.
[16] 西尾 信博. Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children , 2010 .
[17] F. Behm,et al. Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies , 2009, Leukemia.
[18] J. Panetta,et al. Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] P. Pagel,et al. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[20] L. Kanz,et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. , 2006, Experimental hematology.
[21] F. Christiansen,et al. Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. , 2004, Gene.
[22] E. Kinning,et al. Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin , 2002, Bone Marrow Transplantation.
[23] T. Klingebiel,et al. A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen‐disparate haematopoietic stem cells from parental donors , 2001, British journal of haematology.
[24] T. Klingebiel,et al. Transplantation of Megadoses of Purified Haploidentical Stem Cells , 1999, Annals of the New York Academy of Sciences.
[25] T. Klingebiel,et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. , 1999, Journal of hematotherapy.